Novel factor VII gene mutations in six families with hereditary coagulation factor VII deficiency

Xiaoyu Zhang,Shuwen Wang,Shaoqiu Leng,Qi Feng,Yanqi Zhang,Shuqian Xu,Lei Zhang,Xinsheng Zhang,Yunhai Fang,Jun Peng,Zi Sheng

DOI: https://doi.org/10.1002/jcla.23905

IF: 3.124

2021-08-02

Journal of Clinical Laboratory Analysis

Abstract:IntroductionHereditary human coagulation factor VII (FVII) deficiency is an inherited autosomal recessive hemorrhagic disease involving mutations in the F7 gene. The sites and types of F7 mutations may influence the coagulation activities of plasma FVII (FVII: C) and severity of hemorrhage symptoms. However, the specific mutations that impact FVII activity are not completely known. MethodsWe tested the coagulation functions and plasma activities of FVII in seven patients recruited from six families with hereditary FVII deficiency and sequenced the F7 gene of the patients and their families. Then, we analyzed the genetic information from the six families and predicted the structures of the mutated proteins. ResultsIn this study, we detected 11 F7 mutations, including four novel mutations, in which the mutations p.Phe84Ser and p.Gly156Cys encoded the Gla and EGF domains of FVII, respectively, while the mutation p.Ser339Leu encoded the recognition site of the enzymatic protein and maintained the conformation of the catalytic domain structure. Meanwhile, the mutation in the 5′ untranslated region (UTR) was closely associated with the mRNA regulatory sequence. ConclusionWe have identified novel genetic mutations and performed pedigree analysis that shed light on the pathogenesis of hereditary human coagulation FVII deficiency and may contribute to the development of treatments for this disease.

medical laboratory technology

What problem does this paper attempt to address?

The paper aims to study new mutations in patients with hereditary coagulation factor VII (FVII) deficiency from six families. Specifically, the authors conducted coagulation function tests and gene sequencing on seven patients from different families and some of their family members, discovering 11 F7 gene mutations, including four previously unreported new mutations. These mutations are located in different domains of the FVII protein, such as the Gla domain, EGF-like domain, and serine protease catalytic domain. By analyzing the impact of these mutations on FVII activity, the researchers hope to further elucidate the pathogenesis of hereditary FVII deficiency and provide a theoretical basis for the effective treatment of this disease. Additionally, the study explored the relationship between these mutation sites and clinical symptoms, finding that certain specific mutations may be associated with severe bleeding manifestations.